Evidence map›Paper›PMID 39404693›Full record

ArticleExploration of digestive diseases2023

Alcohol-related liver disease: also a question of what you drink?

Finn Jung, Victor Sánchez, Annette Brandt, Ina Bergheim

Abstract read
In one paragraph

Article in Exploration of digestive diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Finn JungDepartment of Nutritional Sciences, Molecular Nutritional Science, University of Vienna, A-1090 Vienna, Austria.ORCID https://orcid.org/0000-0002-8513-140X
Victor SánchezDepartment of Nutritional Sciences, Molecular Nutritional Science, University of Vienna, A-1090 Vienna, Austria.ORCID https://orcid.org/0000-0003-0878-7744
Annette BrandtDepartment of Nutritional Sciences, Molecular Nutritional Science, University of Vienna, A-1090 Vienna, Austria.ORCID https://orcid.org/0000-0002-3934-747X
Ina BergheimDepartment of Nutritional Sciences, Molecular Nutritional Science, University of Vienna, A-1090 Vienna, Austria.ORCID https://orcid.org/0000-0002-3356-4115

Funding

Austrian Science Fund FWF P 32164
6 · The paper itself

Abstract

Excessive alcohol intake is still among the leading causes of chronic liver diseases. Epidemiological studies suggest that per capita consumption of alcohol from various alcohol beverages e.g., beer, wine, or spirits, differs markedly between different areas of the world. Studies further suggest that different alcoholic beverages may impact the development of alcohol-related liver diseases (ALD) differentially. Specifically, results of several more recent epidemiological studies suggest that consumption of wine and herein especially of red wine may be less harmful in relation to the development of liver diseases than the intake of hard spirits. Results of studies evaluating the effects of beer on the development of ALD in humans are rather contradictory. Here, results of studies assessing the impact of wine, beer, and spirits on the development of ALD as well as possible underlying mechanisms are summarized and discussed.

Indexed as

Beerethanolhopresveratrolspiritswine

Identifiers

PMID39404693
PMCPMC7616590

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.